Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

EOSCUSD

(EOSCUSD)

Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
1:07PMiHub NewswireFeaturedCannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA
07/29/202411:15AMEdgar (US Regulatory)Form SC 13D - General Statement of Acquisition of Beneficial OwnershipNYSE:HLGNHeliogen Inc
07/29/202411:15AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:INDVIndivior PLC
07/29/202411:15AMBusiness WirePropel Fuels’s Trade Secret Theft Case Against Phillips 66 Scheduled for Trial August 26, 2024
07/29/202411:15AMPR Newswire (US)ILLY FIRST HALF 2024 RESULTS
07/29/202411:15AMPR Newswire (US)Podcast Journalism: reVolver Podcasts Launches "Testigo Directo"
07/29/202411:15AMPR Newswire (US)ILLY FIRST HALF 2024 RESULTS
07/29/202411:15AMPR Newswire (US)U.S. Minority Business Development Agency and Urban Strategies, Inc. Announce New Partnership to Strengthen Opportunities and Access for Minority Businesses
07/29/202411:14AMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:JPM-MJP Morgan Chase and Co
07/29/202411:12AMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:TDToronto Dominion Bank
07/29/202411:12AMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:JPM-MJP Morgan Chase and Co
07/29/202411:12AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:PHRPhreesia Inc
07/29/202411:12AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:INDVIndivior PLC
07/29/202411:12AMPR Newswire (US)Menarini Announces Positive Topline Data from Pivotal Phase 3 BROOKLYN Clinical Trial Evaluating Efficacy, Safety and Tolerability of Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia
07/29/202411:11AMPR Newswire (Canada)Menarini Announces Positive Topline Data from Pivotal Phase 3 BROOKLYN Clinical Trial Evaluating Efficacy, Safety and Tolerability of Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia
07/29/202411:11AMPR Newswire (US)Menarini Announces Positive Topline Data from Pivotal Phase 3 BROOKLYN Clinical Trial Evaluating Efficacy, Safety and Tolerability of Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia
07/29/202411:10AMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:JPM-MJP Morgan Chase and Co
07/29/202411:10AMAlliance NewsAlliance NewsUK chancellor sets out plan to deal with "GBP22 billion" budget hole
07/29/202411:09AMGlobeNewswire Inc.Porsche celebrates 25 years of automotive technical training excellence
07/29/202411:08AMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:JPM-MJP Morgan Chase and Co
07/29/202411:08AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:INDVIndivior PLC
07/29/202411:07AMPR Newswire (US)Patients in Hospitals that Provide Inpatient Addiction Services Were More Likely to Start and Continue Lifesaving Medication for Opioid Use Disorder Treatment After Discharge
07/29/202411:06AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FLWS1 800 Flowers Com
07/29/202411:06AMGlobeNewswire Inc.Federal Home Loan Bank of New York Announces $5 Million in Small Business Grant Funding
07/29/202411:05AMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:GS-JGoldman Sachs Group Inc
07/29/202411:04AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:RCGRENN Fund Inc
07/29/202411:04AMEdgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNYSE:JPM-MJP Morgan Chase and Co
07/29/202411:04AMBusiness WireGrant Thornton names 56 new partners, principals and managing directors
07/29/202411:02AMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:FBGXUBS AG FI Enhanced Large Cap Growth
07/29/202411:02AMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:JPM-MJP Morgan Chase and Co